Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 43

Sort by

Sort Order Select

Journal Articles

Risk Factors for Overall Survival in Patients with Acute Myeloid Leukemia (AML) with Normal Karyotype Undergoing Allogeneic Stem Cell Transplantation (allo-SCT) in First Complete Remission (CR1): A Report On 366 Patients From the Acute Leukemia Working Party of EBMT

Blood (2012) 120 (21): 1975.

https://doi.org/10.1182/blood.V120.21.1975.1975

Published: 2012

Journal Articles

Influence of Cytogenetic, Molecular Abnormalities and Other Risk Factors on the Outcomes of Children with Acute Myelogenous Leukemia Given An Unrelated Cord Blood Transplantation. A Survey on Behalf of Eurocord, ALWP and PDWP of EBMT

Renato Cunha, MD, Gerard Michel, Tracey O'Brien, Mair Pedro de Souza, Henrique Bittencourt, Gérard Socié, Pierre Bordigoni, Franco Locatelli, MD, Mouhab Ayas, Anna Paola Iori, Ajay J Vora, Jean-Hugues Dalle, José Sanches Toledo, Annalisa Ruggeri, MD, Mohamad Mohty, Christina Peters, MD, Eliane Gluckman, MD, PhD, Vanderson Rocha, MD, PhD

Blood (2011) 118 (21): 834.

https://doi.org/10.1182/blood.V118.21.834.834

Published: 2011

Journal Articles

Impact of Antithymocyte Globulin-Containing Conditioning Regimens on Patients Undergoing Allogeneic Stem Cell Transplantation for Progressive Myelodysplastic Syndrome: A Report From the SFGM-TC Group

Blood (2011) 118 (21): 3035.

https://doi.org/10.1182/blood.V118.21.3035.3035

Published: 2011

Journal Articles

Is there still a place for myeloablative regimen to transplant young adults with sickle cell disease?

Mathieu Kuentz, Marie Robin, Nathalie Dhedin, Yosr Hicheri, Regis Peffault de Latour, Pierre Rohrlich, Pierre Bordigoni, Bénédicte Bruno, Gérard Socié, Françoise Bernaudin

Blood (2011) 118 (16): 4491–4492.

https://doi.org/10.1182/blood-2011-07-367490

Published: 2011

Journal Articles

Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities

Marion Le Meignen, Pascal Auquier, Vincent Barlogis, Nicolas Sirvent, Audrey Contet, Marie-Claude Simeoni, Claire Galambrun, Marilyne Poirée, Pascal Chastagner, Barbara Play, Virginie Villes, Julie Berbis, Hervé Chambost, Pierre Bordigoni, Gérard Michel

Blood (2011) 118 (6): 1481–1489.

https://doi.org/10.1182/blood-2011-01-332866

Published: 2011

Journal Articles

Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia

Claire Oudin, Marie-Claude Simeoni, Nicolas Sirvent, Audrey Contet, Audrey Begu-Le Coroller, Pierre Bordigoni, Catherine Curtillet, Maryline Poirée, Isabelle Thuret, Barbara Play, Mara Carazza Massot, Pascal Chastagner, Hervé Chambost, Pascal Auquier, Gérard Michel

Blood (2011) 117 (17): 4442–4448.

https://doi.org/10.1182/blood-2010-09-304899

Published: 2011

Journal Articles

Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)

Blood (2011) 117 (5): 1522–1529.

https://doi.org/10.1182/blood-2010-07-298372

Published: 2011

Includes: Supplemental data

Journal Articles

Allogeneic Stem Cell Transplantation for Blast Crisis (BC) Chronic Myelogenous Leukemia (CML) In the Tyrosine Kinase Inhibitors (TKIs) Era. Analysis of Pre-Transplant Variables on Transplant Outcome. On Behalf of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire and the French Group of CML

Blood (2010) 116 (21): 2266.

https://doi.org/10.1182/blood.V116.21.2266.2266

Published: 2010

Journal Articles

Interactions Between Total Nucleated and CD34 Cell Dose and Their Impact on Outcomes After Single and Double Unrelated Cord Blood Transplantation for Patients with Hematological Malignancies. An Analysis on Behalf of Societe' Française De Greffe De Moelle Et Therapie Cellulaire (SFGM-TC) and Eurocord

Mauricette Michallet, Renato L.G. Cunha, Gérard Michel, Gérard Socié, Mohamad Mohty, Bernard Rio, MD, Didier Blaise, MD, Anne Sirvent, MD, Reza Tabrizzi, Pierre Bordigoni, Eric Deconinck, Ibrahim Yakoubagha, Jean-François Rossi, Natacha Maillard, Mohamad Sobh, Federico Garnier, MD, Annalisa Ruggeri, MD, Eliane Gluckman, MD, Vanderson Rocha, MD, PhD

Blood (2010) 116 (21): 361.

https://doi.org/10.1182/blood.V116.21.361.361

Published: 2010

Journal Articles

Myeloablative Bone Marrow Transplantation in Young Adults with Sickle Cell Disease: the French Experience

Mathieu Kuentz, Marie Robin, Nathalie Dhedin, Cécile Pautas, Regis Peffaut De La Tour, Pierre Rohrlich, Pierre Bordigoni, Gérard Socié, Catherine Cordonnier, Francoise Bernaudin

Blood (2010) 116 (21): 3516.

https://doi.org/10.1182/blood.V116.21.3516.3516

Published: 2010

Journal Articles

Related Myeloablative Stem Cell Transplantation (SCT) to Cure Sickle Cell Anemia (SCA): Update of French Results

Blood (2010) 116 (21): 3518.

https://doi.org/10.1182/blood.V116.21.3518.3518

Published: 2010

Journal Articles

Rituximab In Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Chronic Lymphocytic Leukemia with Fludarabine + Total Body Irradiation Conditioning: Results of a Phase II Prospective Multicenter Study (ITAC 02-02)

Mauricette Michallet, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Mohamad Mohty, Gerard Socie, Reza Tabrizi, Noel Milpied, MD, Pierre Bordigoni, MD, Nathalie Tedone, CRA, Jacques-Olivier Bay, MD, PhD, Didier Blaise, MD

Blood (2010) 116 (21): 3520.

https://doi.org/10.1182/blood.V116.21.3520.3520

Published: 2010

Journal Articles

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Multicenter Open French Study In High-Risk pediatrics

Blood (2010) 116 (21): 534.

https://doi.org/10.1182/blood.V116.21.534.534

Published: 2010

Journal Articles

Disease Status Is the Major Prognosis Factor for Allogenic Transplantation Outcome for Hodgkin Lymphoma: a Retrospective Study From the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)

Blood (2010) 116 (21): 2359.

https://doi.org/10.1182/blood.V116.21.2359.2359

Published: 2010

Journal Articles

Multicenter survey on the outcome of transplantation of hematopoietic cells in patients with the complete form of DiGeorge anomaly

Ales Janda, Petr Sedlacek, Manfred Hönig, Wilhelm Friedrich, Martin Champagne, Tadashi Matsumoto, Alain Fischer, Benedicte Neven, Audrey Contet, Danielle Bensoussan, Pierre Bordigoni, David Loeb, William Savage, Nada Jabado, Francisco A. Bonilla, Mary A. Slatter, E. Graham Davies, Andrew R. Gennery

Blood (2010) 116 (13): 2229–2236.

https://doi.org/10.1182/blood-2010-03-275966

Published: 2010

Includes: Supplemental data

Journal Articles

Safety and Efficacy of FLAMSA Regimen Followed by Allogeneic Hematopoietic Stem Cell Transplantation From Related and Unrelated Donors in High Risk Acute Leukemia and MDS Patients: A Study From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry.

Blood (2009) 114 (22): 4335.

https://doi.org/10.1182/blood.V114.22.4335.4335

Published: 2009

Journal Articles

Imatinib Is Efficient but Has a Negative Impact On Growth in Children with Previously Untreated chronic Myelogenous Leukaemia (CML) in Early Chronic Phase (CP): Results of the French National Phase IV Trial.

Frédéric Millot, MD, Andre Baruchel, MD, Joelle Guilhot, BS, Arnaud Petit, MD, Thierry Leblanc, MD, Yves Bertrand, MD, Françoise Mazingue, Lutz Patrick, MD, Cécile Vérité, MD, Christian Berthoux, MD, Claire Galambrun, MD, Frédéric Bernard, MD, Karima Yacouben, MD, Pierre Bordigoni, Pr, Christine Edan, MD, Yves Reguerre, MD, Gérard Couillaud, MD, Jean-Michel Cayuela, MD, François Guilhot, MD

Blood (2009) 114 (22): 863.

https://doi.org/10.1182/blood.V114.22.863.863

Published: 2009

Journal Articles

The Use of Bone Marrow Graft for Hematopoietic Stem Cell Transplantation From Matched Unrelated Donors After Reduced Intensity Conditioning Regimen Improves Survival : Analysis of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire.

Andrea Toma, Marie-Lorraine Balère-Appert, Jean-Michel Boiron, MD, Pierre Bordigoni, Pr, Gerard Socie, MD, PhD, Jean-Paul Vernant, Pr, Marc Renaud, MD, Noel Milpied, MD, PhD, Mauricette Michallet, MD, PhD, Eric Deconinck, Pr, Denis Guyotat, MD, PhD, Frederic Garban, MD, Anne Sirvent, MD, Nathalie Contentin, MD, Didier Blaise, Pr, Evelyne Marry, Agnes Buzyn, Pr

Blood (2009) 114 (22): 873.

https://doi.org/10.1182/blood.V114.22.873.873

Published: 2009

Journal Articles

Double Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: French Society of Bone Marrow Graft Transplantation and Cellular Therapy Experience

Jacques-Olivier Bay, Aurelie Cabrespine-Faugeras, Reza Tabrizi, Pierre Bordigoni, Karin Bilger, Marc Renaud, Valerie Mialou, Marie Robin, Mathieu Kuentz, Patrice Chevallier, Nathalie Dhedin, Jean-Yves Cahn, Michel Attal, Didier Blaise, Mauricette Michallet

Blood (2008) 112 (11): 4293.

https://doi.org/10.1182/blood.V112.11.4293.4293

Published: 2008

Journal Articles

Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC allo-SCT) for Patients with High-Risk Multiple Myeloma (MM): A Survey from the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire.

Mohamad Mohty, MD, PhD, Le Quoc-Hung, Franck E Nicolini, MD, PhD, Frederic Garban, MD, Gerard Socie, Michel Attal, MD, Noel- Jean Milpied, PhD, Bruno Lioure, MD, Pierre Bordigoni, MD, Ibrahim Yakoub-Agha, MD, PhD, Jean-Henri Bourhis, Bernard Rio, Eric Deconinck, Marc Renaud, MD, Jean-Luc Harousseau, Didier Blaise, MD, Mauricette Michallet, MD

Blood (2008) 112 (11): 2165.

https://doi.org/10.1182/blood.V112.11.2165.2165

Published: 2008

NARROW

Risk Factors for Overall Survival in Patients with Acute Myeloid Leukemia (AML) with Normal Karyotype Undergoing Allogeneic Stem Cell Transplantation (allo-SCT) in First Complete Remission (CR1): A Report On 366 Patients From the Acute Leukemia Working Party of EBMT

Influence of Cytogenetic, Molecular Abnormalities and Other Risk Factors on the Outcomes of Children with Acute Myelogenous Leukemia Given An Unrelated Cord Blood Transplantation. A Survey on Behalf of Eurocord, ALWP and PDWP of EBMT

Impact of Antithymocyte Globulin-Containing Conditioning Regimens on Patients Undergoing Allogeneic Stem Cell Transplantation for Progressive Myelodysplastic Syndrome: A Report From the SFGM-TC Group

Is there still a place for myeloablative regimen to transplant young adults with sickle cell disease?

Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities

Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia

Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)

Myeloablative Bone Marrow Transplantation in Young Adults with Sickle Cell Disease: the French Experience

Related Myeloablative Stem Cell Transplantation (SCT) to Cure Sickle Cell Anemia (SCA): Update of French Results

Rituximab In Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Chronic Lymphocytic Leukemia with Fludarabine + Total Body Irradiation Conditioning: Results of a Phase II Prospective Multicenter Study (ITAC 02-02)

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Multicenter Open French Study In High-Risk pediatrics

Disease Status Is the Major Prognosis Factor for Allogenic Transplantation Outcome for Hodgkin Lymphoma: a Retrospective Study From the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)

Multicenter survey on the outcome of transplantation of hematopoietic cells in patients with the complete form of DiGeorge anomaly

Safety and Efficacy of FLAMSA Regimen Followed by Allogeneic Hematopoietic Stem Cell Transplantation From Related and Unrelated Donors in High Risk Acute Leukemia and MDS Patients: A Study From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry.

Imatinib Is Efficient but Has a Negative Impact On Growth in Children with Previously Untreated chronic Myelogenous Leukaemia (CML) in Early Chronic Phase (CP): Results of the French National Phase IV Trial.

The Use of Bone Marrow Graft for Hematopoietic Stem Cell Transplantation From Matched Unrelated Donors After Reduced Intensity Conditioning Regimen Improves Survival : Analysis of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire.

Double Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: French Society of Bone Marrow Graft Transplantation and Cellular Therapy Experience

Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC allo-SCT) for Patients with High-Risk Multiple Myeloma (MM): A Survey from the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only